首页> 美国卫生研究院文献>AAPS PharmSci >The Poorly Membrane Permeable Antipsychotic Drugs Amisulpride and Sulpiride Are Substrates of the Organic Cation Transporters from the SLC22 Family
【2h】

The Poorly Membrane Permeable Antipsychotic Drugs Amisulpride and Sulpiride Are Substrates of the Organic Cation Transporters from the SLC22 Family

机译:膜通透性较弱的抗精神病药氨磺必利和舒必利是SLC22家族有机阳离子转运蛋白的底物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Variations in influx transport at the blood-brain barrier might affect the concentration of psychotropic drugs at their site of action and as a consequence might alter therapy response. Furthermore, influx transporters in organs such as the gut, liver and kidney may influence absorption, distribution, and elimination. Here, we analyzed 30 commonly used psychotropic drugs using a parallel artificial membrane permeability assay. Amisulpride and sulpiride showed the lowest membrane permeability (Pe < 1.5 × 10−6 cm/s) and will require influx transport to penetrate the blood-brain barrier and other physiological barriers. We then studied the uptake of amisulpride and sulpiride by the organic cation transporters of the SLC22 family OCT1, OCT2, OCT3, OCTN1, and OCTN2 Amisulpride was found to be transported by all five transporters studied. In contrast, sulpiride was only transported by OCT1 and OCT2. OCT1 showed the highest transport ability both for amisulpride (CLint = 1.9 ml/min/mg protein) and sulpiride (CLint = 4.2 ml/min/mg protein) and polymorphisms in OCT1 significantly reduced the uptake of both drugs. Furthermore, we observed carrier-mediated uptake that was inhibitable by known OCT inhibitors in the immortalized human brain microvascular endothelial cell line hCMEC/D3. In conclusion, this study demonstrates that amisulpride and sulpiride are substrates of organic cation transporters of the SLC22 family. SLC22 transporters may play an important role in the distribution of amisulpride and sulpiride, including their ability to penetrate the blood-brain barrier.Electronic supplementary materialThe online version of this article (doi:10.1208/s12248-014-9649-9) contains supplementary material, which is available to authorized users.
机译:血脑屏障中的流入转运变化可能影响精神药物在其作用部位的浓度,因此可能改变治疗反应。此外,内脏,肝脏和肾脏等器官中的内向转运蛋白可能会影响吸收,分布和消除。在这里,我们使用平行人工膜通透性分析法分析了30种常用的精神药物。氨磺必利和舒必利显示出最低的膜通透性(Pe <1.5×10 −6 cm / s),将需要大量的转运才能穿透血脑屏障和其他生理屏障。然后,我们研究了SLC22家族OCT1,OCT2,OCT3,OCTN1和OCTN2的有机阳离子转运蛋白对氨磺必利和舒必利的吸收。研究发现,所有五个转运蛋白都可以转运氨磺必利。相反,舒必利仅由OCT1和OCT2转运。 OCT1对氨磺必利(CLint = 1.9 ml / min / mg蛋白)和舒必利(CLint = 4.2 ml / min / mg蛋白)都具有最高的转运能力,OCT1中的多态性显着降低了两种药物的摄取。此外,我们观察到在永生化的人脑微血管内皮细胞系hCMEC / D3中,已知的OCT抑制剂可抑制载体介导的摄取。总之,这项研究表明氨磺必利和磺必利是SLC22家族有机阳离子转运蛋白的底物。 SLC22转运蛋白可能在氨磺必利和舒必利的分布中起重要作用,包括它们穿透血脑屏障的能力。电子补充材料本文的在线版本(doi:10.1208 / s12248-014-9649-9)包含补充材料,可供授权用户使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号